Walgreens stock forecast a strong driver for the Walgreens stock

A strong driver for the Walgreens stock forecast could be the rollout of VillageMD clinics inside stores, yet the capex burden limits aggressive EPS expansion. Sector peer comparisons show WBA underperforming CVS by roughly 7% YTD. Also Read: Walgreens Faces Strategic Challenges, Analysts Are Cautiously Optimistic Walgreens third quarter results were much improved over its second quarter when the company in March reported a $2.8 billion loss thanks to a large impairment charge related to its struggling doctor-staffed clinic investment in VillageMD. Walgreens stock forecast reflects mixed sentiment in early 2024 trading, with WBA hovering near $21.40 after modest gains driven by restructuring initiatives. Analysts project a 12‑month target ranging between $19 and $25, factoring in retail pharmacy headwinds and cost‑cutting measures.